Table 2 Disease characteristics, baseline disease activity scores and pharmacological treatment of patients in the exercise and non-exercising disease control groups

 Ulcerative Colitis

8 (61.5%)

5 (71.4%)

0.658^a

 Crohn’s Disease

5 (38.5%)

2 (28.6%)

 Age at diagnosis (years)

25 (25, 31)

26 (22, 31)

0.642

 Previous surgery for condition

Yes: 1 (7.7%)

Yes: 0

0.452^a

 Simple Colitis Index

1.5 (1, 2.75)

1 (0, 4)

0.833

 Harvey Bradshaw Index

1 (0, 1.5)

1 (0, 1)

1.00

 Current steroid use

None

None

 Steroid use in the last year (%)

Yes: 5 (38.5%) No: 8 (61.5%)

Yes: 3 (42.9%) No: 4 (57.1%)

0.848^a

 Current anti-TNF treatment

Yes: 2 (15.4%) No: 11 (84.6%)

Yes: 1 (14.3%) No: 6 (85.7%)

0.948^a

 Currently on immunomodulation

Yes: 100%

Yes: 100%

 Azathioprine

N = 1

N = 1

 Mesalazine

N = 11

N = 6

 6-mercaptopurine

N = 4

N = 2

 Proton pump inhibitors

N = 4

N = 4